Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCC

Abstract

Background This study aimed to clarify the population in whom the presence of metabolic dysfunction-associated fatty liver disease (MAFLD) especially contributes to recurrence after liver resection for non-B, non-C hepatocellular carcinoma (NBNC-HCC). Methods Of the 199 patients who underwent liver resection for NBNC-HCC, those who exceeded Milan criteria and with pathologically proven vascular invasion, intrahepatic metastasis, and positive resection margins were excluded, and the remaining 94 were eligible for this study. We explored factors contributing to postoperative recurrence in populations with and without advanced liver fibrosis. Results Independent factors contributing to postoperative recurrence in the study population were male sex (P = 0.023) and presence of type 2 diabetes (DM) (P = 0.006) and advanced liver fibrosis (P < 0.001). Factors in cases with advanced liver fibrosis (n = 43) were non-overweight (P = 0.02), type 2 DM (P = 0.006), and preoperative alpha-fetoprotein level of 8.2 ng/ml or higher (P = 0.021). In cases without advanced liver fibrosis (n = 51), only presence of all three MAFLD criteria was related to recurrence. Conclusion Liver fibrosis is a strong factor contributing to postoperative recurrence of NBNC-HCC, as previously reported. In patients with advanced liver fibrosis, presence of type 2 DM was the only factor associated with recurrence among MAFLD criteria. On the other hand, in patients without advanced liver fibrosis, the combination of all MAFLD criteria, rather than a specific criterion alone, contributed to recurrence. MAFLD criteria were found to have utility as predictors of postoperative recurrence in NBNC-HCC.